Treatment of essential thrombocytopenia patients intolerant/ resistant to hydroxyurea: A physician survey.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18565
Abstract: e18565Introduction: Hydroxyurea (HU) is deemed first-line cytoreductive therapy for patients with essential thrombocythemia (ET) at high-risk for vascular complications with 20-25% of patients deve... read more here.
Keywords: intolerant resistant; essential thrombocytopenia; thrombocytopenia patients; hydroxyurea ... See more keywords